Stock listing

OTC:LIPO Lipella Pharmaceuticals, Inc. Stock

Follow Lipella Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · OTC:LIPO

$0.0004 USD 0.0000 (0.0%)

Close on Nov 19, 2026 · Data provided by Twelve Data

Past year +100.0% · daily closes, Aug 4, 2026 – Nov 19, 2026, adjusted for splits
Day range
$0.0004 – $0.0004 USDNov 19, 2026
Traded on an average day
$1 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Lipella Pharmaceuticals, Inc. logo

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · OTC:LIPO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.0004-0.0002-33.3%$0.0004$0.0004$0.00041,205
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.0006+0.0001+20.0%$0.0006$0.0006$0.000643,343
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005-0.0001-16.7%$0.0005$0.0005$0.0005645
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.0006+0.0001+20.0%$0.0006$0.0006$0.0006353
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00051,682
$0.00050.00000.0%$0.0005$0.0005$0.0005915
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005310
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005-0.0001-16.7%$0.0005$0.0005$0.0005400
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.00060.00000.0%$0.0006$0.0006$0.00060
$0.0006+0.0001+20.0%$0.0006$0.0006$0.0006236
$0.00050.00000.0%$0.0005$0.0005$0.0005300
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00052,894
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005594
$0.00050.00000.0%$0.0005$0.0005$0.0005100
$0.00050.00000.0%$0.0005$0.0005$0.00052,037
$0.00050.00000.0%$0.0005$0.0005$0.00055,993
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00051,001
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005217
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005400
$0.00050.00000.0%$0.0005$0.0005$0.00051,487
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00051,061
$0.0005+0.0001+25.0%$0.0005$0.0005$0.0005632
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.000422,509
$0.00040.00000.0%$0.0004$0.0004$0.0004500
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00041,512
Ticker
OTC:LIPO
Asset type
Stock
Exchange
OTC
Currency
USD

Lipella Pharmaceuticals, Inc. on 6ix

Decks
14 decks · latest Sep 18, 2025

Valuation

balance Sep 30, 2025 · price Nov 19, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.75

Decks

DeckKindSlidesDate
Investor Presentation (September 2025)Investor deck29 slidesSep 18, 2025
2025 BIO CEO & Investor ConferenceConference39 slidesFeb 11, 2025
Investor Presentation (November 2024)Investor deck21 slidesNovember 2024
H.C. Wainwright 26th Annual Global Investment Conference (September 2024)Conference21 slidesSeptember 2024
Investor Presentation (July 2024)Investor deck22 slidesJuly 2024
Investor Presentation (April 2024)Investor deck21 slidesApril 2024
Investor Presentation (February 2024)Investor deck21 slidesFebruary 2024
Investor Presentation (January 2024)Investor deck25 slidesJanuary 2024
Investor Presentation (September 2023)Investor deck25 slidesSep 11, 2023
Investor Presentation (September 2023)Investor deck25 slidesSeptember 2023
All 14 decks
DeckKindSlidesDate
Investor Presentation (March 2023)Investor deck27 slidesMarch 2023
Biotech Showcase 2023Conference19 slidesFeb 2, 2023
Biotech Showcase 2023Conference16 slidesJan 12, 2023
Investor Presentation (January 2023)Investor deck23 slidesJanuary 2023

Open Decks

IPO

Priced at US$5.75 a share on Dec 19, 2022.

Price
US$5.75 a share
Offering size
US$7 million
Underwriters' option
Up to 182,608 more shares
Listing
LIPO on the Nasdaq Capital Market
Underwriter
Spartan Capital Securities, LLC
Shares delivered
On or about Dec 22, 2022

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 14, 2022
Filed publiclyJul 29, 2022
Amended 5 timesNewest Dec 15, 2022
Shares registered with an exchangeDec 19, 2022
Declared effective by the SECDec 19, 2022
Final prospectus, with the priceDec 21, 2022

Open IPO · From the cover of the final prospectus (424B4) filed Dec 21, 2022

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021
Revenue536.4K449.6K184.2K259.3K
Research and development3.61M3.04M2.55M1.46M
Operating income-5.08M-4.75M-2.59M-1.92M
Depreciation and amortization2.89K1.69K00
EBITDA-5.08M-4.74M-2.59M-1.92M
Interest expense10.8K9.61K6.83K
Income before tax-5.02M-4.62M-2.60M-1.87M
Net income-5.02M-4.62M-2.60M-1.87M
Earnings per share, basic-4.79-6.16-0.64-0.55
Earnings per share, diluted-4.79-6.16-0.64-0.55

Balance sheet

LineFY2024FY2023FY2022FY2021
Cash and equivalents2.18M3.29M5.12M1.41M
Short-term investments300.5K
Receivables84.7K32.3K113.7K
Current assets2.62M3.43M5.80M1.81M
Property, plant and equipment9.86K12.8K
Total assets2.67M3.58M5.95M2.01M
Accounts payable388.2K138.0K384.4K46.9K
Current liabilities754.4K385.4K1.18M340.6K
Total liabilities754.4K432.7K1.27M589.3K
Shareholders' equity1.92M3.14M4.68M1.42M
Shares outstanding1.21M756.7K5.74M3.87M

Cash flow

LineFY2024FY2023FY2022FY2021
Cash from operations-3.95M-3.15M-1.83M-989.3K
Capital spending-14.4K
Free cash flow-3.16M
Cash from investing-14.4K300.5K-300.5K
Cash from financing2.84M1.34M5.24M2.10M
Change in cash-1.11M-1.83M3.71M807.1K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportJul 15, 2026Current reportSEC
8-K · Current reportMar 30, 2026Current reportSEC
8-K · Current reportFeb 4, 2026Management or board changeSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
8-K · Current reportOct 21, 2025Management or board changeSEC
8-K · Current reportOct 9, 2025Management or board changeSEC
25-NSEOct 6, 2025Other filingsSEC
8-K · Current reportSep 18, 2025Current reportSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportJun 25, 2025Current reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportJun 20, 2025Current reportSEC
8-K · Current reportJun 16, 2025Current reportSEC
PRE 14A · Preliminary proxy statementJun 10, 2025Meeting noticeSEC
8-K · Current reportMay 16, 2025Current reportSEC
8-K · Current reportMay 15, 2025Current reportSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 1, 2025Big-stake noticeSEC
8-K · Current reportApr 14, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 9, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 9, 2025Big-stake noticeSEC
8-K · Current reportApr 9, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 7, 2025Big-stake noticeSEC
4 · Change in ownershipApr 7, 2025Insider tradeSEC
8-K · Current reportApr 7, 2025Material contractSEC
424B5 · ProspectusApr 4, 2025Offer documentSEC
424B3 · ProspectusApr 4, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 4, 2025Other filingsSEC
CORRESP · Letter to the SECApr 1, 2025Other filingsSEC
DMar 31, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 31, 2025Other filingsSEC
S-3 · Registration statementMar 28, 2025Offer documentSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 19, 2025Big-stake noticeSEC
8-K · Current reportMar 18, 2025Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 17, 2025Big-stake noticeSEC
4 · Change in ownershipMar 17, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 11, 2025Big-stake noticeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
8-K · Current reportMar 11, 2025Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 3, 2025Big-stake noticeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
8-K · Current reportMar 3, 2025Material contractSEC
8-K · Current reportFeb 24, 2025Material contractSEC
8-K · Current reportFeb 11, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 10, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 10, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 30, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 30, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 23, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 23, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 17, 2025Big-stake noticeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
424B3 · ProspectusJan 16, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 16, 2025Other filingsSEC
CORRESP · Letter to the SECJan 13, 2025Other filingsSEC
UPLOAD · Letter from the SECJan 13, 2025Other filingsSEC
8-K · Current reportJan 13, 2025Current reportSEC
DJan 7, 2025Other filingsSEC
S-3 · Registration statementJan 7, 2025Offer documentSEC
8-K · Current reportJan 6, 2025Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 3, 2025Big-stake noticeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 3, 2025Big-stake noticeSEC
8-K · Current reportDec 30, 2024Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 27, 2024Big-stake noticeSEC
4 · Change in ownershipDec 27, 2024Insider tradeSEC
8-K · Current reportDec 27, 2024Current reportSEC
DEFA14A · Additional proxy materialDec 20, 2024Meeting noticeSEC
8-K · Current reportDec 20, 2024Current reportSEC
8-K · Current reportDec 10, 2024Material contractSEC
DEFA14A · Additional proxy materialDec 6, 2024Meeting noticeSEC
8-K · Current reportDec 6, 2024Current reportSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
DEF 14A · Proxy statementNov 12, 2024Meeting noticeSEC
8-K · Current reportNov 7, 2024Current reportSEC
PRE 14A · Preliminary proxy statementNov 1, 2024Meeting noticeSEC
8-K · Current reportNov 1, 2024Current reportSEC
8-K · Current reportOct 18, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedOct 17, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedOct 17, 2024Big-stake noticeSEC
8-K · Current reportSep 11, 2024Meeting outcomeSEC
8-K · Current reportAug 23, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedAug 19, 2024Big-stake noticeSEC
DAug 14, 2024Other filingsSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
ARS · Annual report to shareholdersAug 12, 2024Annual reportSEC
DEF 14A · Proxy statementAug 12, 2024Meeting noticeSEC
8-K · Current reportAug 6, 2024Current reportSEC
8-K · Current reportAug 1, 2024Material contractSEC
424B5 · ProspectusAug 1, 2024Offer documentSEC
PRE 14A · Preliminary proxy statementJul 30, 2024Meeting noticeSEC
4 · Change in ownershipMay 15, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedMay 6, 2024Big-stake noticeSEC
8-K · Current reportApr 19, 2024Current reportSEC
8-K · Current reportApr 12, 2024Current reportSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMar 19, 2024Big-stake noticeSEC
8-K · Current reportMar 15, 2024Material contractSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
4 · Change in ownershipMar 15, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMar 15, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedMar 15, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansMar 15, 2024Offer documentSEC
SC 13D/A · Big-stake notice, amendedMar 6, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedMar 6, 2024Big-stake noticeSEC
424B3 · ProspectusFeb 27, 2024Offer documentSEC
10-K · Annual reportFeb 27, 2024Annual reportSEC
EFFECT · Notice that a registration is effectiveFeb 9, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 7, 2024Big-stake noticeSEC
CORRESP · Letter to the SECFeb 6, 2024Other filingsSEC
UPLOAD · Letter from the SECFeb 6, 2024Other filingsSEC
S-3 · Registration statementFeb 1, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedJan 25, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJan 3, 2024Big-stake noticeSEC
8-K · Current reportNov 30, 2023Current reportSEC
8-K · Current reportNov 28, 2023Current reportSEC
8-K · Current reportNov 22, 2023Meeting outcomeSEC
424B3 · ProspectusNov 14, 2023Offer documentSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
424B3 · ProspectusNov 9, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 9, 2023Other filingsSEC
DNov 7, 2023Other filingsSEC
CORRESP · Letter to the SECNov 6, 2023Other filingsSEC
UPLOAD · Letter from the SECNov 6, 2023Other filingsSEC
S-1 · Registration statementNov 1, 2023Offer documentSEC
8-K · Current reportOct 25, 2023Material contractSEC
DEFA14A · Additional proxy materialOct 10, 2023Meeting noticeSEC
DEF 14A · Proxy statementOct 10, 2023Meeting noticeSEC
DSep 12, 2023Other filingsSEC
8-K · Current reportSep 11, 2023Current reportSEC
424B3 · ProspectusAug 14, 2023Offer documentSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
8-K · Current reportAug 8, 2023Material contractSEC
8-K · Current reportAug 2, 2023Material contractSEC
8-K · Current reportJun 23, 2023Management or board changeSEC
SC 13D/A · Big-stake notice, amendedJun 21, 2023Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJun 21, 2023Big-stake noticeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
4 · Change in ownershipJun 21, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 21, 2023Insider tradeSEC
S-8 POSJun 6, 2023Offer documentSEC
S-8 · Registration statement for employee plansJun 2, 2023Offer documentSEC
8-K · Current reportJun 1, 2023Management or board changeSEC
8-K · Current reportMay 15, 2023ResultsSEC
424B3 · ProspectusMay 12, 2023Offer documentSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
8-K · Current reportApr 3, 2023ResultsSEC
424B3 · ProspectusApr 3, 2023Offer documentSEC
POS EXApr 3, 2023Other filingsSEC
10-K · Annual reportMar 31, 2023Annual reportSEC
3 · Initial statement of ownershipMar 30, 2023Insider tradeSEC
SC 13G · Big-stake noticeMar 29, 2023Big-stake noticeSEC
8-K · Current reportMar 27, 2023Management or board changeSEC
SC 13G · Big-stake noticeFeb 9, 2023Big-stake noticeSEC
8-K/A · Current report, amendedFeb 2, 2023Current reportSEC
8-K · Current reportJan 11, 2023Current reportSEC
3 · Initial statement of ownershipJan 3, 2023Insider tradeSEC
3 · Initial statement of ownershipJan 3, 2023Insider tradeSEC
SC 13D · Big-stake noticeDec 29, 2022Big-stake noticeSEC
SC 13D · Big-stake noticeDec 29, 2022Big-stake noticeSEC
4 · Change in ownershipDec 27, 2022Insider tradeSEC
424B4 · ProspectusDec 21, 2022Offer documentSEC
424B4 · ProspectusDec 21, 2022Offer documentSEC
3 · Initial statement of ownershipDec 20, 2022Insider tradeSEC
3 · Initial statement of ownershipDec 20, 2022Insider tradeSEC
3 · Initial statement of ownershipDec 20, 2022Insider tradeSEC
3 · Initial statement of ownershipDec 20, 2022Insider tradeSEC
3 · Initial statement of ownershipDec 20, 2022Insider tradeSEC
CERT · Exchange's certificate of listingDec 20, 2022Other filingsSEC
EFFECT · Notice that a registration is effectiveDec 20, 2022Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeDec 19, 2022Other filingsSEC
CORRESP · Letter to the SECDec 16, 2022Other filingsSEC
CORRESP · Letter to the SECDec 15, 2022Other filingsSEC
S-1/A · Registration statement, amendedDec 15, 2022Offer documentSEC
CORRESP · Letter to the SECDec 13, 2022Other filingsSEC
S-1/A · Registration statement, amendedDec 13, 2022Offer documentSEC
UPLOAD · Letter from the SECDec 12, 2022Other filingsSEC
CORRESP · Letter to the SECDec 8, 2022Other filingsSEC
S-1/A · Registration statement, amendedDec 8, 2022Offer documentSEC
UPLOAD · Letter from the SECDec 5, 2022Other filingsSEC
CORRESP · Letter to the SECNov 28, 2022Other filingsSEC
S-1/A · Registration statement, amendedNov 28, 2022Offer documentSEC
UPLOAD · Letter from the SECNov 4, 2022Other filingsSEC
CORRESP · Letter to the SECOct 31, 2022Other filingsSEC

This page holds 200 of 225 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David S Battleman
Other companies: Scopus BioPharma, Inc. (Director · Dec 16, 2020 – Dec 16, 2020 · Past); PAVmed Inc. (Director · Aug 3, 2017 – Apr 1, 2021 · Past)
Director · Dec 19, 2022 – Jun 16, 2023 · Past
Byong KimDirector · Dec 19, 2022 – Mar 15, 2024 · Past
Douglas JohnstonChief Financial Officer · Dec 19, 2022 – Mar 15, 2024 · Past
Jonathan H KaufmanSee remarks below., Director · Mar 13, 2024 – Apr 3, 2025 · Past
Lori BirderDirector · Jun 17, 2023 – Mar 15, 2024 · Past
Michael B ChancellorChief Medical Officer, Director · Mar 13, 2024 – Mar 15, 2024 · Past
Naoki YoshimuraDirector · Dec 19, 2022 – Mar 15, 2024 · Past
Ryan PruchnicDirector · Dec 19, 2022 – Mar 15, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Lipella Pharmaceuticals, Inc.